Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …

This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …

Background & Aims Long-term outcomes of patients with branch-duct intraductal papillary
mucinous neoplasms (IPMNs), particularly those after 5 years of surveillance, have not been …

Background & Aims To successfully implement imaging-based pancreatic cancer (PC)
surveillance, understanding the timeline and morphologic features of neoplastic progression …

Background & Aims It is not clear how endoscopic screening for gastric cancer affects
incidence or mortality. We performed a systematic review and meta-analysis to evaluate the …

Due to its poor prognosis and the late stage at which it is typically diagnosed, early detection
of pancreatic cancer is a pressing clinical problem. Advances in genomic analysis of human …

Background Rapid access to pancreatic imaging and regular pancreatic surveillance may
help identify stage I pancreatic cancer. We investigated recent trends in the stage of newly …

The number of new cases of pancreatic ductal adenocarcinoma is increasing with a
cumulative total of 495,773 cases worldwide, making it the fourteenth most common …

Background & aims Pancreatic cystic lesions (PCLs) are frequent incidental findings. As
most PCLs require costly diagnostic evaluation and active surveillance, it is important to …

The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …